Variant report

Variant	esv3355830
Chromosome Location	chr5:61601020-61603768
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:768)
CpG islands
(count:551)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:768 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:61601596-61602035	K562	blood:	n/a	n/a
2	ARID3A	chr5:61602387-61602432	HepG2	liver:	n/a	n/a
3	ATF1	chr5:61601469-61601973	K562	blood:	n/a	n/a
4	ATF1	chr5:61602787-61603228	K562	blood:	n/a	n/a
5	ATF2	chr5:61602882-61603260	GM12878	blood:	n/a	n/a
6	ATF2	chr5:61601195-61601869	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF2	chr5:61601440-61601953	GM12878	blood:	n/a	n/a
8	ATF2	chr5:61601492-61602007	GM12878	blood:	n/a	n/a
9	ATF2	chr5:61602618-61603330	GM12878	blood:	n/a	n/a
10	ATF3	chr5:61601549-61601955	K562	blood:	n/a	n/a
11	BACH1	chr5:61602999-61603280	K562	blood:	n/a	n/a
12	BACH1	chr5:61601831-61602559	H1-hESC	embryonic stem cell:	n/a	n/a
13	BCL3	chr5:61601415-61601940	A549	lung:	n/a	chr5:61601867-61601880 chr5:61601883-61601896 chr5:61601868-61601881
14	BCLAF1	chr5:61602783-61603393	GM12878	blood:	n/a	n/a
15	BCLAF1	chr5:61601477-61602220	GM12878	blood:	n/a	chr5:61601867-61601880 chr5:61602011-61602024 chr5:61601883-61601896 chr5:61601868-61601881
16	BCLAF1	chr5:61601428-61602051	GM12878	blood:	n/a	chr5:61601867-61601880 chr5:61602011-61602024 chr5:61601883-61601896 chr5:61601868-61601881
17	BCLAF1	chr5:61602781-61603443	GM12878	blood:	n/a	n/a
18	BHLHE40	chr5:61602847-61603375	GM12878	blood:	n/a	n/a
19	BHLHE40	chr5:61601570-61602612	GM12878	blood:	n/a	chr5:61602007-61602023 chr5:61601867-61601883 chr5:61602537-61602553 chr5:61602540-61602556 chr5:61601877-61601893 chr5:61602479-61602495
20	BHLHE40	chr5:61601099-61602473	K562	blood:	n/a	chr5:61602007-61602023 chr5:61601867-61601883 chr5:61601877-61601893
21	BHLHE40	chr5:61601580-61602118	HepG2	liver:	n/a	chr5:61602007-61602023 chr5:61601867-61601883 chr5:61601877-61601893
22	BHLHE40	chr5:61602853-61603191	K562	blood:	n/a	n/a
23	BRCA1	chr5:61601511-61602024	Hela-S3	cervix:	n/a	n/a
24	BRCA1	chr5:61601502-61601950	GM12878	blood:	n/a	n/a
25	BRCA1	chr5:61602907-61603079	GM12878	blood:	n/a	n/a
26	BRCA1	chr5:61601412-61601789	H1-hESC	embryonic stem cell:	n/a	n/a
27	CBX3	chr5:61601212-61601893	K562	blood:	n/a	n/a
28	CBX3	chr5:61602698-61603302	K562	blood:	n/a	n/a
29	CBX3	chr5:61600931-61602228	K562	blood:	n/a	n/a
30	CCNT2	chr5:61601589-61602764	K562	blood:	n/a	n/a
31	CEBPB	chr5:61602390-61602537	HepG2	liver:	n/a	n/a
32	CEBPB	chr5:61601615-61602641	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr5:61601964-61602021	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPD	chr5:61601974-61602222	HepG2	liver:	n/a	n/a
35	CEBPD	chr5:61601920-61602480	HepG2	liver:	n/a	n/a
36	CHD1	chr5:61602713-61603393	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD1	chr5:61602328-61603430	GM12878	blood:	n/a	n/a
38	CHD1	chr5:61601425-61602126	GM12878	blood:	n/a	n/a
39	CHD2	chr5:61601377-61601879	HepG2	liver:	n/a	n/a
40	CHD2	chr5:61603256-61603452	K562	blood:	n/a	n/a
41	CHD2	chr5:61601529-61603289	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr5:61601480-61603312	GM12878	blood:	n/a	n/a
43	CHD2	chr5:61602089-61602560	HepG2	liver:	n/a	n/a
44	CHD2	chr5:61601394-61601927	H1-hESC	embryonic stem cell:	n/a	n/a
45	CHD2	chr5:61601096-61603020	K562	blood:	n/a	n/a
46	CREB1	chr5:61601452-61603144	HepG2	liver:	n/a	n/a
47	CREB1	chr5:61602686-61603128	H1-hESC	embryonic stem cell:	n/a	n/a
48	CREB1	chr5:61601389-61603298	GM12878	blood:	n/a	n/a
49	CREB1	chr5:61602495-61603150	H1-hESC	embryonic stem cell:	n/a	n/a
50	CREB1	chr5:61601441-61602577	A549	lung:	n/a	n/a

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:61601529-61601579	HRPEpiC	eye:	n/a
2	chr5:61602127-61602177	NHDF-neo	bronchial:	n/a
3	chr5:61601529-61601579	HRPEpiC	eye:	n/a
4	chr5:61602127-61602177	NHDF-neo	bronchial:	n/a
5	chr5:61601636-61601686	HNPCEpiC	eye:	n/a
6	chr5:61601636-61601686	HUVEC	blood vessel:	n/a
7	chr5:61601636-61601686	K562	blood:	n/a
8	chr5:61601128-61601178	SAEC	small airway:	n/a
9	chr5:61602105-61602155	GM19239	blood:	n/a
10	chr5:61602127-61602177	A549	lung:	n/a
11	chr5:61601636-61601686	ProgFib	skin:	n/a
12	chr5:61602737-61602787	SK-N-SH_RA	brain:	n/a
13	chr5:61601128-61601178	GM12891	blood:	n/a
14	chr5:61601529-61601579	PANC-1	pancreas:	n/a
15	chr5:61602127-61602177	HRCEpiC	kidney:	n/a
16	chr5:61602105-61602155	H1-hESC	embryonic stem cell:	embryo
17	chr5:61601647-61601697	HRE	kidney:	n/a
18	chr5:61603122-61603172	AG10803	skin:	n/a
19	chr5:61601529-61601579	T-47D	breast:	n/a
20	chr5:61601629-61601679	GM12878	blood:	n/a
21	chr5:61601128-61601178	CMK	blood:	n/a
22	chr5:61601647-61601697	SK-N-SH_RA	brain:	n/a
23	chr5:61601647-61601697	GM06990	blood:	n/a
24	chr5:61602127-61602177	HIPEpiC	eye:	n/a
25	chr5:61603122-61603172	AoSMC	blood vessel:	n/a
26	chr5:61602737-61602787	HCT-116	colon:	n/a
27	chr5:61602737-61602787	NH-A	brain:	n/a
28	chr5:61603122-61603172	HMEC	breast:	n/a
29	chr5:61601629-61601679	HCT-116	colon:	n/a
30	chr5:61601647-61601697	HUVEC	blood vessel:	n/a
31	chr5:61602737-61602787	HepG2	liver:	n/a
32	chr5:61602737-61602787	AG09319	gingival:	n/a
33	chr5:61603122-61603172	HRE	kidney:	n/a
34	chr5:61601647-61601697	MCF10A-Er-Src	breast:	n/a
35	chr5:61601629-61601679	HEK293	kidney:	embryo
36	chr5:61601636-61601686	RPTEC	kidney:	n/a
37	chr5:61602127-61602177	AG10803	skin:	n/a
38	chr5:61601647-61601697	ECC-1	luminal epithelium:	n/a
39	chr5:61601529-61601579	HIPEpiC	eye:	n/a
40	chr5:61601128-61601178	NB4	blood:	n/a
41	chr5:61602737-61602787	MCF-7	breast:	n/a
42	chr5:61601647-61601697	CMK	blood:	n/a
43	chr5:61601529-61601579	HRCEpiC	kidney:	n/a
44	chr5:61602737-61602787	Hela-S3	cervix:	n/a
45	chr5:61603122-61603172	HUVEC	blood vessel:	n/a
46	chr5:61601636-61601686	HPAEpiC	pulmonary alveolar:	n/a
47	chr5:61603122-61603172	AG09309	skin:	n/a
48	chr5:61601629-61601679	T-47D	breast:	n/a
49	chr5:61601647-61601697	HCM	heart:	n/a
50	chr5:61603122-61603172	HAEpiC	amniotic membrane:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:61601958..61603491-chr5:61698096..61700949,2	MCF-7	breast:
2	chr5:61602672..61603442-chr7:75544017..75544556,2	Hela-S3	cervix:
3	chr5:61601759..61603415-chr5:61698105..61699743,2	K562	blood:
4	chr5:61601799..61604714-chr5:61698844..61701505,2	MCF-7	breast:
5	chr5:61593661..61595529-chr5:61600373..61601956,2	K562	blood:
6	chr5:61591991..61594374-chr5:61603392..61605599,2	K562	blood:
7	chr5:61601533..61603969-chr5:61707379..61709702,2	K562	blood:
8	chr10:94050798..94051586-chr5:61601516..61602145,2	Hela-S3	cervix:

No data

Variant related genes	Relation type
KIF2A	TF binding region
KIF2A	CpG island
ENSG00000198060	chromatin interactions
ENSG00000107864	chromatin interactions
ENSG00000086200	chromatin interactions
ENSG00000265020	chromatin interactions
ENSG00000127948	chromatin interactions
ENSG00000086189	chromatin interactions

Extended variants
information (count: 106 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:106 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs571772688	chr5:61601029-61601030	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs527786289	chr5:61601041-61601042	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs574728235	chr5:61601076-61601077	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs113231457	chr5:61601078-61601079	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs547917187	chr5:61601093-61601094	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs78342713	chr5:61601101-61601102	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs536683389	chr5:61601113-61601114	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs556113817	chr5:61601128-61601129	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs141861597	chr5:61601158-61601159	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs544532034	chr5:61601159-61601160	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs191110986	chr5:61601180-61601181	Active TSS Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs147104380	chr5:61601290-61601291	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs577818252	chr5:61601316-61601317	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs529930241	chr5:61601330-61601331	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs533741215	chr5:61601349-61601350	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs553868312	chr5:61601359-61601360	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs148145160	chr5:61601381-61601382	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs184745784	chr5:61601467-61601468	Flanking Active TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs562433277	chr5:61601492-61601493	Flanking Active TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs549196285	chr5:61601515-61601516	Flanking Active TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs576818327	chr5:61601535-61601536	Flanking Active TSS Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs141932212	chr5:61601556-61601557	Flanking Active TSS Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs565436630	chr5:61601577-61601578	Flanking Active TSS Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs561474367	chr5:61601590-61601591	Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs527924489	chr5:61601621-61601622	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs150662013	chr5:61601636-61601637	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs561458795	chr5:61601679-61601680	Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs530104717	chr5:61601729-61601730	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs549776154	chr5:61601753-61601754	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs138838827	chr5:61601756-61601757	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs189295494	chr5:61601799-61601800	Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs551698333	chr5:61601831-61601832	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs149374211	chr5:61601856-61601857	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs534022181	chr5:61601886-61601887	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs553658699	chr5:61601891-61601892	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs528464053	chr5:61601921-61601922	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs536313145	chr5:61601956-61601957	Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs556198528	chr5:61602007-61602008	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs146315657	chr5:61602011-61602012	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs545010869	chr5:61602018-61602019	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs565606347	chr5:61602025-61602026	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs181824384	chr5:61602038-61602039	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs545406148	chr5:61602045-61602046	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs141968809	chr5:61602050-61602051	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs561287890	chr5:61602062-61602063	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs530141539	chr5:61602065-61602066	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs549814828	chr5:61602108-61602109	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs13184453	chr5:61602198-61602199	Active TSS Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs563434700	chr5:61602219-61602220	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs374889152	chr5:61602263-61602264	Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17133270	CNVD
Breast cancer	19602461	CNVD
Renal cell carcinoma	18194544	CNVD
abnormal development	18461090	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Neuroticism	17667963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Acute lymphoblastic leukemia	22237106	CNVD

Chromatin state (count:448 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:61596200-61601200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
2	chr5:61600400-61601200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
3	chr5:61600600-61601200	Enhancers	Primary T cells fromperipheralblood	blood
4	chr5:61600800-61601200	Enhancers	H1 Cell Line	embryonic stem cell
5	chr5:61600800-61601200	Enhancers	Primary T helper naive cells from peripheral blood	blood
6	chr5:61600800-61601200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
7	chr5:61600800-61601200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
8	chr5:61600800-61601200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
9	chr5:61600800-61601200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
10	chr5:61600800-61601200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
11	chr5:61600800-61601200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr5:61600800-61601800	Flanking Active TSS	Dnd41	blood
13	chr5:61601000-61601200	Active TSS	ES-I3 Cell Line	embryonic stem cell
14	chr5:61601000-61601200	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr5:61601000-61601200	Enhancers	iPS-15b Cell Line	embryonic stem cell
16	chr5:61601000-61601200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr5:61601000-61601200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr5:61601000-61601200	Enhancers	Primary monocytes fromperipheralblood	blood
19	chr5:61601000-61601200	Active TSS	Primary neutrophils fromperipheralblood	blood
20	chr5:61601000-61601200	Enhancers	Primary B cells from cord blood	blood
21	chr5:61601000-61601200	Enhancers	Primary B cells from peripheral blood	blood
22	chr5:61601000-61601200	Enhancers	Primary hematopoietic stem cells short term culture	blood
23	chr5:61601000-61601200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr5:61601000-61601200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr5:61601000-61601200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr5:61601000-61601200	Enhancers	Adipose Nuclei	Adipose
27	chr5:61601000-61601200	Enhancers	Liver	Liver
28	chr5:61601000-61601200	Enhancers	Brain Angular Gyrus	brain
29	chr5:61601000-61601200	Enhancers	Brain Anterior Caudate	brain
30	chr5:61601000-61601200	Enhancers	Brain Cingulate Gyrus	brain
31	chr5:61601000-61601200	Enhancers	Brain Germinal Matrix	brain
32	chr5:61601000-61601200	Enhancers	Brain Inferior Temporal Lobe	brain
33	chr5:61601000-61601200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
34	chr5:61601000-61601200	Enhancers	Brain Substantia Nigra	brain
35	chr5:61601000-61601200	Enhancers	Colon Smooth Muscle	Colon
36	chr5:61601000-61601200	Enhancers	Duodenum Mucosa	Duodenum
37	chr5:61601000-61601200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr5:61601000-61601200	Active TSS	Fetal Brain Female	brain
39	chr5:61601000-61601200	Enhancers	Fetal Intestine Large	intestine
40	chr5:61601000-61601200	Enhancers	Fetal Intestine Small	intestine
41	chr5:61601000-61601200	Enhancers	Fetal Lung	lung
42	chr5:61601000-61601200	Enhancers	Fetal Stomach	stomach
43	chr5:61601000-61601200	Enhancers	Pancreas	Pancrea
44	chr5:61601000-61601200	Enhancers	Psoas Muscle	Psoas
45	chr5:61601000-61601200	Enhancers	Rectal Mucosa Donor 31	rectum
46	chr5:61601000-61601200	Enhancers	Rectal Smooth Muscle	rectum
47	chr5:61601000-61601200	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr5:61601000-61601200	Enhancers	Skeletal Muscle Female	skeletal muscle
49	chr5:61601000-61601200	Enhancers	Stomach Smooth Muscle	stomach
50	chr5:61601000-61601200	Enhancers	Thymus	Thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links